Science Explorer Back to mapMap
Researcher · Sarah Cannon · United States

Mark R. Olsen

Mark R. Olsen publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Molecular Biology, on topics such as Lung Cancer Treatments and Mutations, Cancer Treatment and Pharmacology and Lung Cancer Research Studies.

OpenAlex
World rank
#2,109,655
of 7,710,434 ranked researchers
Rank in United States
#636,475
of 1,627,098
Works
30
Citations
1.2k
Citations per work
39.5

What does Mark R. Olsen research?

Mark R. Olsen's work is mostly in Medicine (62%), Biochemistry, Genetics and Molecular Biology (26%), Chemistry (4%).

Life Sciences26%Physical Sciences4%Health Sciences62%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1861.6%
    1. Biochemistry, Genetics and Molecular Biology825.6%
  1. Everything else39.3%
    1. Chemistry13.5%
  1. 1Pulmonary and Respiratory Medicine31% of their works
  2. 2Oncology30% of their works
  3. 3Molecular Biology9% of their works
  4. 4Genetics9% of their works
  5. 5Cancer Research7% of their works
  6. 6Organic Chemistry4% of their works

Research topics

Which keywords describe Mark R. Olsen's research?

The keywords of their largest research topics: Clinical Trials, Targeted Therapy, Chemotherapy, Immunotherapy, Prognostic Factors, ALK Inhibitors, EGFR Mutations and Chemotherapy-Induced Peripheral Neuropathy.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Clinical Trials162 topics
  2. Targeted Therapy162 topics
  3. Chemotherapy143 topics
  4. Immunotherapy142 topics
  5. Prognostic Factors142 topics
  6. ALK Inhibitors91 topic
  7. EGFR Mutations91 topic
  8. Chemotherapy-Induced Peripheral Neuropathy71 topic
  9. Genomic Profiles71 topic
  10. Metastatic71 topic
  11. Renal Cell Carcinoma71 topic
  12. Small-Cell Lung Cancer71 topic
  13. Taxanes71 topic
  14. Estrogen61 topic
  15. Immune Checkpoint Blockade61 topic
  16. PD-1 and PD-L161 topic
  17. Receptor61 topic
  18. CT Screening41 topic
  19. Lung Cancer41 topic
  20. Cetuximab31 topic
  21. KRAS Mutations31 topic

Where does Mark R. Olsen work?

Mark R. Olsen's main affiliation in the publication record is Sarah Cannon, United States.

How many publications and citations does Mark R. Olsen have?

OpenAlex counts 30 works and 1,185 citations for Mark R. Olsen, an h-index of 13, ranking #2,109,655 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Mark R. Olsen. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.